Treatment of Hyperproliferative Diseases with Vinca Alkaloid N-Oxide and Analogs
AssigneeStat of Oregon Acting by and Through The Oregon State Board of Higher Education on Behalf of the University of Oregon
InventorsJohn G. Curd, John F.W. Keana, Alshad S. Lalani, Paul B. Westberg, Bradford Goodwin, W. David Henner
Life of this patent
Estimating the term…
Abstract
The present invention relates to vinca alkaloid and analog N-oxides having activity for treating hyperproliferative disorders. Further, the invention relates to pharmaceutical compositions and methods of using vinca alkaloid and analog N-oxides, alone or in combination with one or more other active agents or treatments, to treat hyperproliferative disorders.
Claims51
A compound having formula I:
- or a pharmaceutically acceptable salt thereof, wherein:
- R′1 represents hydrogen, alkyl, alkoxy, acyl, formyl or halogenoacyl group;
- R′2 represents hydrogen or alkyl group;
- R′3 and R″3 are identical or different and each independently represents hydrogen, hydroxy or alkanoyloxy group, or else R′3 and R″3 together form a carbonyl group or else R′3 and R′5 together form an epoxy bridge or a double bond;
- R′4 represents hydrogen, alkyloxycarbonyl, hydroxymethyl or alkanoyloxymethyl group;
- R′5 and R″5 are identical or different and each independently represents hydrogen, hydroxy, alkoxycarbonyl, C1-C7 alkyl optionally substituted with 1-3 halogen atoms, alkanoyloxy, or 2-hydroxyethyl group;
- R′6 represents hydrogen, ethyl, 2-hydroxyethyl or acetyl group;
- R′7 represents hydrogen or cyano;
- R1 represents hydrogen, alkyl, formyl or acyl group;
- R2 represents hydrogen or alkoxy;
- R3 represents hydrogen, hydroxy or alkanoyloxyl group, or else R3 and R4 together form an epoxy bridge or a double bond;
- R4 represents hydrogen, hydroxy or alkanoyloxy group, or else R4 and R5 together form an epoxy bridge;
- R6 represents an alkyloxycarbonyl, hydrazido, acetamido, hydroxymethyl, alkanoyloxymethyl group or —C(═O)-A-NH—P, where -A- is one of —NH—, —NH-alk-COO— or —NH-alk-COONH—, alk is a straight chain or branched C1-C7 alkyl group and —NH—P is a peptide residue, or R5 and R6 together form an oxazolidine-2,4-dione ring;
- R5 and R7 represent hydrogen, hydroxy or alkanoyloxy group, as well as their addition salts with acids and their quaternary ammonium salts;
- each of R8 and R′8 is 0 or is absent provided that at least one of R8 and R′8 is 0;
- and
- n is 1 or 2;
- with the proviso that the compound of Formula I is not vinorelbine N′b-oxide or vinblastine N′b-oxide.
A method of treating, ameliorating, or preventing a hyperproliferative disorder comprising administering to an animal in need thereof a therapeutically effective amount of a compound of Formula I:
- or a pharmaceutically acceptable salt thereof, wherein:
- R′1 represents hydrogen, alkyl, alkoxy, acyl, formyl or halogenoacyl group;
- R′2 represents hydrogen or alkyl group;
- R′3 and R″3 are identical or different and each independently represents hydrogen, hydroxy or alkanoyloxy group, or else R′3 and R″3 together form a carbonyl group or else R′3 and R′5 together form an epoxy bridge or a double bond;
- R′4 represents hydrogen, alkyloxycarbonyl, hydroxymethyl or alkanoyloxymethyl group;
- R′5 and R″5 are identical or different and each independently represents hydrogen, hydroxy, alkoxycarbonyl, C1-C7 alkyl optionally substituted with 1-3 halogen atoms, alkanoyloxy, or 2-hydroxyethyl group;
- R′6 represents hydrogen, ethyl, 2-hydroxyethyl or acetyl group;
- R′7 represents hydrogen or cyano;
- R1 represents hydrogen, alkyl, formyl or acyl group,
- R2 represents hydrogen or alkoxy;
- R3 represents hydrogen, hydroxy or alkanoyloxy group, or else R3 and R4 together form an epoxy bridge or a double bond;
- R4 represents hydrogen, hydroxy or alkanoyloxy group, or else R4 and R5 together form an epoxy bridge;
- R6 represents an alkyloxycarbonyl, hydrazido, acetamido, hydroxymethyl, alkanoyloxymethyl group or —C(═O)-A-NH—P, where -A- is one of —NH—, —NH-alk-COO— or —NH-alk-COONH—, alk is a straight chain or branched C1-C7 alkyl group and —NH—P is a peptide residue, or R5 and R6 together form an oxazolidine-2,4-dione ring;
- R5 and R7 represent hydrogen, hydroxy or alkanoyloxy group, as well as their addition salts with acids and their quaternary ammonium salts;
- each of R8 and R′8 is 0 or is absent provided that at least one of R8 and R18 is 0;
- and
- n is 1 or 2.
A pharmaceutical composition comprising a therapeutically effective amount of a compound of Formula I:
- or a pharmaceutically acceptable salt or diastereomer thereof, wherein:
- R′1 represents hydrogen, alkyl, alkoxy, acyl, formyl or halogenoacyl group;
- R′2 represents hydrogen or alkyl group;
- R′3 and R″3 are identical or different and each independently represents hydrogen, hydroxy or alkanoyloxy group, or else R′3 and R″3 together form a carbonyl group or else R′3 and R′5 together form an epoxy bridge or a double bond;
- R′4 represents hydrogen, alkyloxycarbonyl, hydroxymethyl or alkanoyloxymethyl group;
- R′5 and R″5 are identical or different and each independently represents hydrogen, hydroxy, alkoxycarbonyl, C1-C7 alkyl optionally substituted with 1-3 halogen atoms, alkanoyloxyl, or 2-hydroxyethyl group;
- R′6 represents hydrogen, ethyl, 2-hydroxyethyl or acetyl group;
- R′7 represents hydrogen or cyano;
- R1 represents hydrogen, alkyl, formyl or acyl group,
- R2 represents hydrogen or alkoxy;
- R3 represents hydrogen, hydroxy or alkanoyloxy group, or else R3 and R4 together form an epoxy bridge or a double bond;
- R4 represents hydrogen, hydroxy or alkanoyloxy group, or else R4 and R5 together form an epoxy bridge;
- R6 represents an alkyloxycarbonyl, hydrazido, acetamido, hydroxymethyl, alkanoyloxymethyl group or —C(═O)-A-NH—P, where -A- is one of —NH—, —NH-alk-COO— or —NH-alk-COONH—, alk is a straight chain or branched C1-C7 alkyl group and —NH—P is a peptide residue, or R5 and R6 together form an oxazolidine-2,4-dione ring;
- R5 and R7 represent hydrogen, hydroxy or alkanoyloxy group, as well as their addition salts with acids and their quaternary ammonium salts;
- each of R8 and R′8 is O or is absent provided that at least one of R8 and R′8 is O;
- and
- n is 1 or 2.
Dependencies are inferred from the claim text.